| Autor: |
V A, Filov, M L, Gershanovich, B A, Ivin, L A, Danova, F A, Gurchin, A G, Naryshkin, V I, Leshchinskiĭ, A G, Zemskaia, B M, Nikiforov, P V, Breĭvis |
| Rok vydání: |
1994 |
| Předmět: |
|
| Zdroj: |
Voprosy onkologii. 40(7-12) |
| ISSN: |
0507-3758 |
| Popis: |
The results of segidrin administration to 46 patients with malignant and 6 patients with benign tumors of the brain are presented. Pronounced therapeutic effect for the whole group was 63.5% and 73%, if partial regression of neurologic symptoms in the entire brain and separate foci is considered. These indexes for patients with malignant tumors only were 61 and 71.7%, respectively. Since segidrin has virtually no significant untoward side-effects, it is considered a most safe medicine for managing brain tumors. It is recommended in cases of inoperable tumor and for post-operative adjuvant chemotherapy with a view to extending the patient's survival time and improving the quality of life. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
